Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer
{{output}}
Objective: Thrombocytosis is an adverse prognostic factor in many types of cancer. We investigated if pre-treatment increased platelet counts provide prognostic information specifically in patients with stage III and IV serous ov... ...
